Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Biogen Pharmachem Industries Ltd
Your Vote -
Buy
76.23%
Hold
15.36%
Sell
8.41%
76.23%
345 users have voted
Option Chain
Analyzes market sentiment, predicts Biogen Pharmachem Industries Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Biogen Pharmachem - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2
-
Biogen Pharmachem - Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulatio
-
Biogen Pharmachem - Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St
-
Biogen Pharmachem - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of
-
Biogen Pharmachem - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
-
Biogen Pharmachem - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Biogen Pharmachem - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Biogen Pharmachem - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Biogen Pharmachem has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Biogen Pharmachem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Biogen Pharmachem - Regulation 42 As Per SEBI LODR Intimation Of Record Date For Issuance Of Bonus Shares In The Proportion O
-
Biogen Pharmachem - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Biogen Pharmachem - Clarification For Point No 4 Of The Outcome In Reference To The Outcome Uploaded Of The Board Meeting Hel
-
Biogen Pharmachem - Regulations 30 Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements)
-
Biogen Pharmachem - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd March 2026
-
Biogen Pharmachem - Board Meeting Intimation for Declaration Of Issue Of Bonus Shares.
Key fundamentals
Evaluate the intrinsic value of Biogen Pharmachem Industries Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 99.0871 | 91.9277 | 56.5204 | 54.5897 | 54.1341 |
| Liabilities | 99.0871 | 91.9277 | 56.5204 | 54.5897 | 54.1341 |
| Equity | 90.2603 | 65.2603 | 65.2603 | 65.2603 | 65.2603 |
| Gross Profit | -1.6012 | -1.4904 | -0.4508 | -0.4573 | -0.0151 |
| Net Profit | 0.8595 | -0.2927 | 1.9307 | 0.4555 | -0.0085 |
| Cash From Operating Activities | 1.5682 | -1.082 | 1.9659 | 1.7044 | 1.3983 |
| NPM(%) | 0 | 0 | 0 | 0 | -0.34 |
| Revenue | 0 | 0 | 0 | 0 | 2.4741 |
| Expenses | 1.6012 | 1.4904 | 0.4508 | 0.4573 | 2.4893 |
| ROE(%) | 0.86 | -0.29 | 1.94 | 0.45 | 0 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Biogen Pharmachem Industries Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Visagar Polytex Ltd | 0.52 | 0.00 | 0.00 | 12.00 | -5.68 | 0.00 |
| India Motor Parts and Accessories Ltd | 1016.20 | 0.69 | 13.14 | 0.51 | 773.64 | 0.98 |
| Mihika Industries Ltd | 13.48 | -0.44 | 0.00 | 0.41 | 0.55 | 0.00 |
| Hathway Cable and Datacom Ltd | 10.26 | -1.54 | 22.28 | 72.57 | 23.25 | 0.00 |
Company Info
2008 -Wellworth Overseas Ltd has appointed Mr. Hiteshbhai Natvarlal Parikh as an Additional Director of the Company. 2009 --Registered Office of the Company has been shifted 408, 4th Floor, Saman Complex, Opp: Nalanda Complex, Near Star Apartment, Jodhpur Road, Satellite, Ahmedabad-380015 to 603, 6th Floor, Pratiksha Complex, Near Mahalaxmi Five Roads, Paldi, Ahmedabad -380007. 2011 -Company has changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd. 2012 --Registered Office of the Company has been shifted to 320, Vrundavan Enclave, Near Reliance Petrol Pump, 132ft Ring Road, Near AEC Cross Road, Naranpura Ahmedabad - 380013 2021 -Company name has changed from Sun Techno Overseas to Biogen Pharmachem Industries Ltd
2008 -Wellworth Overseas Ltd has appointed Mr. Hiteshbhai Natvarlal Parikh as an Additional Director of the Company. 2009 --Registered Office of the Company has been shifted 408, 4th Floor, Saman Complex, Opp: Nalanda Complex, Near Star Apartment, Jodhpur Road, Satellite, Ahmedabad-380015 to 603, 6th Floor, Pratiksha Complex, Near Mahalaxmi Five Roads, Paldi, Ahmedabad -380007. 2011 -Company has changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd. 2012 --Registered Office of the Company has been shifted to 320, Vrundavan Enclave, Near Reliance Petrol Pump, 132ft Ring Road, Near AEC Cross Road, Naranpura Ahmedabad - 380013 2021 -Company name has changed from Sun Techno Overseas to Biogen Pharmachem Industries Ltd
Read More
Parent Organisation
Biogen Pharmachem Industries Ltd.
Founded
13/07/1995
Managing Director
NSE Symbol
FAQ
The current price of Biogen Pharmachem Industries Ltd is
The 52-week high for Biogen Pharmachem Industries Ltd is
The market capitalization of Biogen Pharmachem Industries Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Biogen Pharmachem Industries Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Biogen Pharmachem Industries Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Biogen Pharmachem Industries Ltd shares.
The CEO of Biogen Pharmachem Industries Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
